超薄冠状动脉支架之间的比较:一个网络元分析
Giorgio Marengo1, Francesco Bruno1, Luca Scudeler1
1Division of Cardiology, Cardiovascular and Thoracic Department, Città della Salute e della Scienza, University of Turin, Italy.
The American journal of cardiology
|February 1, 2024
概括
超薄的药物排泄支架 (DES) 显示了与较厚的支架DES相比的目标病变衰竭 (TLF). 在超薄选项中,Orsiro在TLF和目标损伤再血管化 (TLR) 中表现最佳的概率最高.
科学领域:
- 心脏病学 心脏病学
- 医疗器械 医疗器械
- 干预心脏病学 干预心脏病学
背景情况:
- 与较厚的支架DES相比,超薄支架药物排泄支架 (DES) 可能提供更好的结果.
- 不同超薄DES设备之间存在有限的比较数据.
研究的目的:
- 为了比较各种超薄DES的疗效和安全性,相互比较和比较较厚的DES.
- 评估目标病变衰竭 (TLF) 和其他关键临床结果在1年的随访.
主要方法:
- 随机对照试验的网络元分析,比较超薄 (<70微米的杆) 和更厚的杆DES在全新人群中.
- 主要终点:目标损伤失败 (TLF) 在1年.
- 二次终点:整体死亡率,心肌梗塞,目标病变再血管化 (TLR) 和支架血栓形成.
主要成果:
- 纳入了9项涉及20081名患者的研究;其中9509人接受了超薄DES (Orsiro,MiStent,Supraflex).
- 一年后,在超薄的DES中没有观察到TLF的显著差异.
- 奥西罗的TLF风险与Supraflex相似,在TLF,心肌梗塞和TLR中表现最佳的概率最高.
结论:
- 超薄的DES显示TLF风险与厚型杆DES相比较.
- 与其他超薄DES和更厚的杆装置相比,Orsiro在TLF和TLR方面表现优越的可能性最高.
相关概念视频
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...